Navigation Links
Genome-wide survey nets key melanoma gene
Date:2/7/2008

urely intracellular.

Green and his colleagues focused their attention on IGFBP7 because its presence suggested something intriguing: If one otherwise healthy melanocyte begins expressing BRAF, the IGFBP7 it produces can enter cells around it, prompting lots of melanocytes to switch off, rather than risking a tumor.

In the experiments reported in Cell, the researchers exposed human melanoma cells in culture to recombinant IGFBP7. The protein had the same genetic code as the human version, but was produced using genetically modified insect cells. The melanoma cells that were treated with IGFBP7 committed suicide-- just as though their anti-cancer mechanism was working correctly.

The researchers also injected the protein into the bloodstream of mice on to which human melanoma tumors had been grafted. IGFBP7 entered the tumor cells and stopped their growth in the mice. Melanoma cells [caused by BRAF mutations] shut off expression of this key regulator, said Green. Because of that, the cells escape from senescence and form a tumor.

According to Green, the research also answers another controversy in the field: Are nevi dead-ends or are they precursors to melanoma" If you go in and see a dermatologist, if they see a mole, they will generally cut it off, he said. They dont want to take the chance that it could be a precursor.

However, Green thinks his results point in the other direction. Because IGFBP7 is a secreted protein, even if one activated BRAF-containing -- but otherwise healthy -- cell in the nevi stopped producing IGFBP7 and threatened to form a tumor, the IGFBP7 being secreted from the cells around it would kill it. Its an extremely powerful anti-cancer mechanism, said Green.

The teams findings are important not only from a research standpoint, but also for future clinical treatments, Green noted. Melanoma can be surgically removed if caught early, but in advanced cases there is really no treatment for it. Green said IGFBP7s ability to
'/>"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
2. Survey reveals disparities in skin cancer knowledge, protection among high school students
3. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
4. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Youth Drug Use at a Five Year Low, New Survey Shows
7. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
8. Parental surveys boost diagnosis abilities of pediatricians
9. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
10. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
11. PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...Nov. 8 Pharmaceutical R...r Vice President Ken Johnson released the followin... bill: ,, "We are disappointed, but not surpris...ions of hardworking Americans as well as nearly ha...ives who voted against the bill. ,, "While well...
(Date:11/8/2009)...s House Passage of Health Care Reform Bill ,, ...mprove coverage for all Americans ,, BALTIMORE...ight the United States House of Representatives pa...would strengthen Medicare for seniors and end disc...ions of Americans out of affordable health coverag...
(Date:11/7/2009).... 7 The American Medica...Director of Health at the Family Violence Preventi...ce today at its semi-annual policy-making meeting....ghest honor the AMA House of Delegates bestows on ...com.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "M...
(Date:11/7/2009)...ithful Catholics have a responsibility to vigorous...e status quo." ,, WASHINGTON, Nov. 7 /PRNew...nt Judie Brown released the following statement on... Speaker Nancy Pelosi,s Affordable Health Care for...eserving the status quo for abortion is voted upon...
(Date:11/7/2009)...ssume that all youth will rebel, expert says , ...are more likely to behave badly if their parents e...nts who believe they are simply being realistic mi...ecy," Christy Buchanan, a psychology professor at ... said in a university news release. "Negative expe...
Breaking Medicine News(10 mins):Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2
...teran nonprofit executive, presided over LiveSTRON...hood injury prevention mission,, WASHINGTON, Apri...ganization dedicated exclusively to child injury,p...scom.com/cgi-bin/prnh/20080410/DC19130-a ), (LOG...
...NTA ANA, Calif., April 10 Integrated,Healthcare H...announced,today it has named Edward S. Gyimah as i...of compliance with government regulation of its,ho...anes-Oxley compliance program. Prior to his employ...
... Researchers at Johns Hopkins have discovered that...l nerve cells with blood pressure controlling prot...ls throughout the body might have the same power o...rowing nerve which way to grow, says David Ginty, ...
...rivative of protein produced by bacteria blocked ...AY, April 10 (HealthDay News) -- A modified versio...imals against the damage caused by the kind of rad... Andrei V. Gudkov, senior vice president for basic...
... Washington, D.C. (April 10, 2008) Carotid arter...tients who are not eligible for surgery, according...England Journal of Medicine. Carotid artery diseas...sults important for the estimated 200,000 American...
...LLAS, April 10 ACCESS PHARMACEUTICALS, INC.,(OTC ...laborators at,prestigious institutes in France and...its lead anticancer compound, ProLindac(TM), at th...esentation entitled "Characterization of predictiv...
Other Medicine News:Health News:Safe Kids Worldwide Names Stoller New President, CEO 2Health News:Safe Kids Worldwide Names Stoller New President, CEO 3Health News:IHHI Announces Chief Compliance Officer Appointment 2Health News:Blood vessels: The pied piper for growing nerve cells 2Health News:New Drug Protects Against Radiation Damage 2Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 2Health News:SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery 3Health News:Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference 2Health News:Access Pharmaceuticals to Present New Data on ProLindac(TM) at the AACR Annual Meeting 2008 Conference 3
(Date:11/6/2009)...TICK, Mass., Nov. 6 Bost...unced that it has reached an agreement in principl...d to product advisories issued by its Guidant subs...ales occurred prior to Boston Scientific,s 2006 ac...previously disclosed an investigation by the U.S. ...
(Date:11/6/2009)...N DIEGO, Nov. 6 Ardea Bi...company focused on the development of small-molecu...and human immunodeficiency virus (HIV), today repo...for the third quarter and nine months ended Septem...om/cgi-bin/prnh/20091104/ARDEALOGO ) ,, "Since ...
(Date:11/6/2009)...LANTA, Nov. 6 GeoVax La..."the Company"), an Atlanta-based, biopharmaceutica...aused by HIV-1 (Human Immunodeficiency Virus) and ... quarter 2009 financial results and provided an op...sident and Chief Executive Officer commented, "We ...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 1Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 2Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 3Alcon Commences Phase 2 Clinical Trial of NovaBays NVC 422 for Viral Conjunctivitis 4680 4Working Out in the Garden 50717 1On Memory Older Americans Outsmart the English 50713 1On Memory Older Americans Outsmart the English 50713 2
Fixed Core Straight Safety Wire Guides - Standard (stainless steel)
Mitty-Pollack Needle Set - Standard
Light Guide Cables - 3.5mm
High Transmission Autoclavable Fiberoptic Light Guide, with 45 angled instrument fitting, snap-on
Medicine Products: